NOTE 3 - EQUITY TRANSACTIONS | NOTE 3 - EQUITY TRANSACTIONS The Company has 500,000,000 shares of common stock authorized with a par value of $0.0001. 25,000,000 shares of common stock were issued to the founder of the Company on incorporation. During the year ended December 31, 2018, the Company sold a total of 63,800 shares of its common stock (and 63,800 Warrants) to investors at a price of $0.50 per share or $31,900 total. On August 1, 2018, the Company issued a total of 10,475,000 shares of its common stock to one consulting firm entity and nine individuals for consulting services to be rendered to the Company pursuant to Consulting Agreements dated August 1, 2018 for terms ranging from 3 to 6 months. The shares were valued at $0.50 per share or $5,237,500 total which was expensed as consulting and business development expenses on the statements of operations over the terms of the respective Consulting Agreements. $1,833,334 (of the $5,237,500 total) was expensed in the three months ended September 30, 2018, $2,574,999 (of the $5,237,500 total) was expensed in the three months ended December 31, 2018, and $829,167 (of the $5,237,500 total) was expensed in the three months ended March 31, 2019. During the three months ended March 31, 2019, the Company sold a total of 200,000 shares of its common stock (and 200,000 Warrants) to an investor at a price of $0.50 per share or $100,000 total. On January 8, 2020, the Company issued 100,000 restricted shares of its common stock to a third party service provider in consideration of consulting services rendered to the Company. The shares were valued at $0.10 per share or $10,000 total which is included in consulting and business development expenses on the statement of operations for the three months ended March 31, 2020. Because there was no market for the common stock at January 8, 2020, the Company estimated the fair value of the issuance at the estimated fair value of the services rendered by the consultant. Warrants A summary of Warrants activity for the years ended December 31, 2018 and 2019, and for the three months ended March 31, 2020 follows: Balance, January 1, 2018 150,000 Issued in 2018 63,800 Balance, December 31, 2018 213,800 Issued in 2019 200,000 Expired in 2019 (150,000) Balance, December 31, 2019 263,800 Issued in the three months ended March 31, 2020 - Expired in the three months ended March 31, 2020 - Balance, March 31, 2020 263,800 Each Warrant is exercisable into shares of our common stock at an exercise price of $1.00 per share and expires two years from the date of its issuance. As of March 31, 2020, there were a total of 263,800 Warrants outstanding (of which 63,800 expire in the three months ending September 30, 2020, and 200,000 expire in the three months ending March 31, 2021. |